The County of Monterey is investigating scams where someone is posing as county officials and emailing fake invoices for over $14,000 to entities involved in projects going before the County's ...

Monterey County Regional Fire District said a building built in the 1800s was burned in a fire Monday morning. Just past midnight, firefighters responded to the corner of Robinson Canyon Road and ...

Madrigal reported better-than-expected Q4 results. The company also announced positive new two-year data from a phase 3 study of its MASH drug Rezdiffra. Madrigal reported fourth-quarter revenue ...

WEST CONSHOHOCKEN, Pa. (AP) — WEST CONSHOHOCKEN, Pa. (AP) — Madrigal Pharmaceuticals Inc. (MDGL) on Wednesday reported a loss of $59.4 million in its fourth quarter. The West Conshohocken ...

Over a dozen quakes clustered in or near Tres Pinos, in San Benito County, were recorded with a range of magnitudes between 2.2 and 3.9, including one in Aromas, which straddles the Monterey ...

WEST PALM BEACH, Fla. -- New York Mets infielder Nick Madrigal dislocated his non-throwing shoulder Sunday in a spring training game against the Washington Nationals. Madrigal is fighting for a ...

Madrigal (shoulder) was placed on the 60-day injured list Monday. It was reported earlier in the day that Madrigal is expected to miss a significant period of time recovering from a fractured left ...

On Wednesday, Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL) reported two-year results from the open-label compensated MASH cirrhosis (F4c) arm of the Phase 3 MAESTRO-NAFLD-1 trial of Rezdiffra ...

Nick Madrigal dislocated his left shoulder during today’s Spring Training split-squad game between the Mets and Nationals. In the first inning of the game, Madrigal (who was playing shortstop ...

Rodin Eckenroth/Getty Images for Gersh; Joe Scarnici; Cindy Gold; Gersh; Ben Esner; Jon Kopaloff As part of a leadership restructure at Gersh, Leslie Siebert has been named sole president and will ...

Madrigal Pharmaceuticals (MDGL) reported Q4 results and provided a 2-year update from the open-label metabolic dysfunction-associated steatohepatitis compensated F4 arm of the Phase 3 MAESTRO ...